Literature DB >> 32750417

Regulation of blood-retinal barrier cell-junctions in diabetic retinopathy.

Madhuri Rudraraju1, S Priya Narayanan2, Payaningal R Somanath3.   

Abstract

Loss of the blood-retinal barrier (BRB) integrity and subsequent damage to the neurovascular unit in the retina are the underlying reasons for diabetic retinopathy (DR). Damage to BRB eventually leads to severe visual impairment in the absence of prompt intervention. Diabetic macular edema and proliferative DR are the advanced stages of the disease where BRB integrity is altered. Primary mechanisms contributing to BRB dysfunction include loss of cell-cell barrier junctions, vascular endothelial growth factor, advanced glycation end products-induced damage, and oxidative stress. Although much is known about the involvement of adherens and tight-junction proteins in the regulation of vascular permeability in various diseases, there is a significant gap in our knowledge on the junctional proteins expressed in the BRB and how BRB function is modulated in the diabetic retina. In this review article, we present our current understanding of the molecular composition of BRB, the changes in the BRB junctional protein turnover in DR, and how BRB functional modulation affects vascular permeability and macular edema in the diabetic retina.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Blood-retinal barrier; Claudins; Diabetic retinopathy; Macular edema; Tight-junction

Year:  2020        PMID: 32750417     DOI: 10.1016/j.phrs.2020.105115

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  18 in total

1.  Cell-cell junctions: structure and regulation in physiology and pathology.

Authors:  Mir S Adil; S Priya Narayanan; Payaningal R Somanath
Journal:  Tissue Barriers       Date:  2020-12-10

2.  Vascular endothelial growth factor-165b protects the blood-retinal barrier from damage after acute high intraocular pressure in rats.

Authors:  Jing Shen; Yi Li; Min Li; Wei-Xian Liu; Hong-Liang Sun; Quan-Peng Zhang; Xi-Nan Yi
Journal:  Int J Ophthalmol       Date:  2022-08-18       Impact factor: 1.645

3.  One-Month Outcomes of Intravitreal Anti-VEGF vs. Dexamethasone Implant in the Treatment of Diabetic Macular Edema in Vitrectomized Eyes.

Authors:  Youling Liang; Bin Yan; Manyun Xie; Zhishang Meng; Jiayue Ma; Bosheng Ma; Jing Luo
Journal:  Front Med (Lausanne)       Date:  2022-06-14

Review 4.  Metallic Engineered Nanomaterials and Ocular Toxicity: A Current Perspective.

Authors:  Krista M Cosert; Soohyun Kim; Iman Jalilian; Maggie Chang; Brooke L Gates; Kent E Pinkerton; Laura S Van Winkle; Vijay Krishna Raghunathan; Brian C Leonard; Sara M Thomasy
Journal:  Pharmaceutics       Date:  2022-05-03       Impact factor: 6.525

5.  Is type 2 diabetes mellitus another intercellular junction-related disorder?

Authors:  Carla B Collares-Buzato; Carolina Pf Carvalho
Journal:  Exp Biol Med (Maywood)       Date:  2022-04-23

6.  The Anti-Inflammatory Effect of the β1-Adrenergic Receptor Antagonist Metoprolol on High Glucose Treated Human Microvascular Retinal Endothelial Cells.

Authors:  Giovanni Giurdanella; Anna Longo; Alfio Distefano; Melania Olivieri; Martina Cristaldi; Alessia Cosentino; Aleksandra Agafonova; Nunzia Caporarello; Gabriella Lupo; Carmelina Daniela Anfuso
Journal:  Cells       Date:  2021-12-24       Impact factor: 6.600

Review 7.  Pyroptosis in the Retinal Neurovascular Unit: New Insights Into Diabetic Retinopathy.

Authors:  Chunren Meng; Chufeng Gu; Shuai He; Tong Su; Thashi Lhamo; Deji Draga; Qinghua Qiu
Journal:  Front Immunol       Date:  2021-10-19       Impact factor: 7.561

8.  MiR-195 inhibits the ubiquitination and degradation of YY1 by Smurf2, and induces EMT and cell permeability of retinal pigment epithelial cells.

Authors:  Shu-Hua Fu; Mei-Chen Lai; Yun-Yao Zheng; Ya-Wen Sun; Jing-Jing Qiu; Fu Gui; Qian Zhang; Fei Liu
Journal:  Cell Death Dis       Date:  2021-07-15       Impact factor: 8.469

Review 9.  Diabetic Retinopathy in the Aging Population: A Perspective of Pathogenesis and Treatment.

Authors:  Sameer P Leley; Thomas A Ciulla; Ashay D Bhatwadekar
Journal:  Clin Interv Aging       Date:  2021-07-15       Impact factor: 4.458

10.  Distinct Mechanisms of Human Retinal Endothelial Barrier Modulation In Vitro by Mediators of Diabetes and Uveitis.

Authors:  Madhuri Rudraraju; S Priya Narayanan; Payaningal R Somanath
Journal:  Life (Basel)       Date:  2021-12-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.